Salesforce (CRM) is set to report fiscal third-quarter results tomorrow after the close of trading, and Wedbush Securities is ...
Wedbush has assumed coverage of Voyager Therapeutics (NASDAQ:VYGR) with an outperform rating, highlighting the company’s ...
Salesforce (CRM) is expected to report strong fiscal third-quarter results this week amid elevated use cases for its entire product portfolio and demand for artificial intelligence solutions, ...
The Stellantis 2024 roller coaster hit a new low with CEO Carlos Tavares’s abrupt resignation. Here are three areas a new CEO ...
Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after ...
The $7 billion RIA welcomes a seasoned professional to help scale the business and draw talent across its private-client and ...
Some panned the billionaire for overspending on Twitter, but the platform is winning him favor with Donald Trump and ...
Rich Franchella joins Procyon to lead business development and recruit advisor teams across the RIA’s business verticals.
Wedbush notes that in the past two weeks Kioxia filed for an IPO and SanDisk released its 10-12B, telling investors that data from these ...
Major technology stocks are positioned for a strong year-end rally as artificial intelligence initiatives accelerate and ...
Wedbush has assumed coverage of Voyager Therapeutics (NASDAQ:VYGR) with an outperform rating, highlighting the company’s TRACER platform. The investment firm said it believes TRACER alone should ...